Skip to main content
. Author manuscript; available in PMC: 2022 Nov 14.
Published in final edited form as: Psychol Med. 2020 Jul 27;51(4):694–701. doi: 10.1017/S0033291720001981

Table 2.

Incidence of any and all psychological morbidities among adults with and without CP or SB with one-year clean enrollment period.

No Outcome at Baseline
Case/Denominator Control/Denominator
Any Psychological Morbidity 4205/10848 (38.8%)* 395275/1635348 (24.2%)
Insomnia 1402/14655 (9.6%)* 105331/1884216 (5.6%)
Adjustment disorders 767/14891 (5.2%)* 63017/1905421 (3.3%)
Anxiety disorders 2568/13560 (18.9%)* 204060/1819089 (11.2%)
PTSD 163/15193 (1.1%)* 8416/1931162 (0.4%)
Delirium/Dementia/Amnestic/Other Cognitive Disorder 990/14826 (6.7%)* 41606/1916260 (2.2%)
Dementias 351/15150 (2.3%)* 19773/1929124 (1.0%)
Impulse control disorders NEC 79/15236 (0.5%) 1592/1934754 (0.1%)
Mood disorders 2524/12898 (19.6%)* 179935/1794787 (10.0%)
Personality disorders 157/15229 (1.0%)* 4790/1933048 (0.2%)
Alcohol-related disorders 341/15112 (2.3%)* 33777/1921455 (1.8%)
Substance-related disorders 731/15043 (4.9%)* 51119/1923254 (2.7%)
Central Pain 1996/14391 (13.9%)* 115911/1898453 (6.1%)
*

P<.01 and standard mean difference (SMD) ≥0.2

Denominators for both cases and controls reflect a one-year clean period during their enrollment for the specific condition. For instance, among cases (CP/SB), there exist 14,655 patients whose first year of enrollment had no evidence of insomnia; therefore, inferred incident insomnia could be estimated for this subset of the full CP/SB cohort. As a result, all patient cohorts’ denominators dynamically change conditional on the incident outcome being measured to ensure a clean period in the first year of enrollment